EUVIMEDEUVIMED entdecken
Crossref

First-in-Class Dual Targeting Compounds for the Management of Seizures in Glucose Transporter Type 1 Deficiency Syndrome

Andrea Angeli iD, Marta Ferraroni iD, Carlotta Granchi iD, Filippo Minutolo, Xiaozhuo Chen, Pratik Shriwas, Emilio Russo, Antonio Leo, Silvia Selleri, Fabrizio Carta iD, Claudiu T Supuran iD

Journal of Medicinal Chemistry · 2023

DOI: 10.1021/acs.jmedchem.3c00938 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Andrea Angeli und 10 weiteren Autor:innen. Beteiligte Einrichtung: NEUROFARBA Department, Sezione di Scienze Farmaceutiche e Nutraceutiche, University of Florence, Via Ugo Schiff 6, Sesto Fiorentino, Florence 50019, …. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The genetic disorder glucose transporter type 1 deficiency syndrome (GLUT1-DS) heavily affects the main intake of energy in tissues and determines the most relevant outcomes at the central nervous system (CNS) district, which is highly dependent on glucose. Herein, we report the design and development of a set of compounds bearing the glucosyl and galactosyl moieties. We assessed their ability to enhance the GLUT1 mediated glucose intake in non-small-cell lung cancer (NSCLC) cells and to inhibit the carbonic anhydrase (CA; EC 4.2.1.1) isoforms implicated in the physiopathology of uncontrolled seizures associated to epilepsy (i.e., I, II, IV, VA, VB, and XII). The binding mode of 8 in adduct with hCA II was determined by X-ray crystallography. Among the selected derivatives, compound 4b proved effective in suppressing the occurrence of uncontrolled seizures on the in vivo induced maximal electroshock (MES) model and thus gives sustainment of an unprecedently reported pharmacological approach for the management of GLUT1-DS associated diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsCarcinoma, Non-Small-Cell LungSeizuresCarbonic Anhydrase IXHumansGlucose Transporter Type 1Carbonic Anhydrase InhibitorsCarbohydrate Metabolism, Inborn ErrorsStructure-Activity RelationshipMonosaccharide Transport Proteins

Substanzen

Carbonic Anhydrase IXGlucose Transporter Type 1Carbonic Anhydrase InhibitorsMonosaccharide Transport Proteins

Autor:innen und Institutionen

  • NEUROFARBA Department, Sezione di Scienze Farmaceutiche e Nutraceutiche, University of Florence, Via Ugo Schiff 6, Sesto Fiorentino, Florence 50019, Italy.
  • Department of Chemistry "Ugo Schiff", University of Florence, Via della Lastruccia 3-13, Sesto Fiorentino, Florence I-50019, Italy.
  • Department of Pharmacy, University of Pisa, Via Bonanno 6, Pisa 56126, Italy.
  • Edison Biotechnology Institute, Department of Biological Sciences, Molecular and Cellular Biology Program, Ohio University, Athens, Ohio 45701, United States.
  • School of Medicine, Science of Health Department, FAS@UMG Research Center, University of Catanzaro, 88100 Catanzaro, Italy.

ORCID-Profile: Andrea Angeli, Marta Ferraroni, Carlotta Granchi, Fabrizio Carta, Claudiu T Supuran

Zitieren

APA

Angeli, A., Ferraroni, M., Granchi, C., Minutolo, F., Chen, X., Shriwas, P., Russo, E., Leo, A., Selleri, S., Carta, F., & Supuran, C. T. (2023). First-in-Class Dual Targeting Compounds for the Management of Seizures in Glucose Transporter Type 1 Deficiency Syndrome. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.3c00938

Vancouver

Angeli A, Ferraroni M, Granchi C, Minutolo F, Chen X, Shriwas P, et al. First-in-Class Dual Targeting Compounds for the Management of Seizures in Glucose Transporter Type 1 Deficiency Syndrome. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.3c00938

BibTeX
@article{Angeli2023,
  author = {Angeli, Andrea and Ferraroni, Marta and Granchi, Carlotta and Minutolo, Filippo and Chen, Xiaozhuo and Shriwas, Pratik and Russo, Emilio and Leo, Antonio and Selleri, Silvia and Carta, Fabrizio and Supuran, Claudiu T},
  title = {First-in-Class Dual Targeting Compounds for the Management of Seizures in Glucose Transporter Type 1 Deficiency Syndrome},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  doi = {10.1021/acs.jmedchem.3c00938}
}
Kostenlos starten →